vs
Axogen, Inc.（AXGN）与迈心诺（MASI）财务数据对比。点击上方公司名可切换其他公司
迈心诺的季度营收约是Axogen, Inc.的6.2倍（$371.5M vs $59.9M）。Axogen, Inc.净利率更高（-22.0% vs -27.0%，领先5.1%）。Axogen, Inc.同比增速更快（21.3% vs -26.4%）。迈心诺自由现金流更多（$50.9M vs $1.8M）。过去两年Axogen, Inc.的营收复合增速更高（20.3% vs -17.7%）
Axogen总部位于美国佛罗里达州阿拉楚阿，是外科解决方案提供商，专注开发周围神经损伤修复相关产品，涵盖人体组织移植物、神经连接器、软组织膜等，旗下AVANCE细胞移植技术可模拟人体神经结构，临床数据显示其产品帮助87%的周围神经损伤患者实现感觉与运动功能恢复，2013年完成1800万美元首次公开募股。
迈心诺（Masimo Corporation）是总部位于美国加利福尼亚州尔湾的健康科技及消费电子企业，核心产品包括面向医院及家用场景的患者监护设备、无创传感器及配套软件平台，同时也布局了消费级音频和可穿戴设备赛道。
AXGN vs MASI — 直观对比
营收规模更大
MASI
是对方的6.2倍
$59.9M
营收增速更快
AXGN
高出47.6%
-26.4%
净利率更高
AXGN
高出5.1%
-27.0%
自由现金流更多
MASI
多$49.1M
$1.8M
两年增速更快
AXGN
近两年复合增速
-17.7%
损益表 — Q4 2025 vs Q3 2026
| 指标 | | |
|---|---|---|
| 营收 | $59.9M | $371.5M |
| 净利润 | $-13.2M | $-100.4M |
| 毛利率 | 74.1% | 62.1% |
| 营业利润率 | -16.3% | 22.5% |
| 净利率 | -22.0% | -27.0% |
| 营收同比 | 21.3% | -26.4% |
| 净利润同比 | -3023.6% | -1124.5% |
| 每股收益（稀释后） | $-0.28 | $-1.84 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AXGNMASI
| Q4 25 | $59.9M | — | ||
| Q3 25 | $60.1M | $371.5M | ||
| Q2 25 | $56.7M | $370.9M | ||
| Q1 25 | $48.6M | $372.0M | ||
| Q4 24 | $49.4M | $600.7M | ||
| Q3 24 | $48.6M | $504.6M | ||
| Q2 24 | $47.9M | $496.3M | ||
| Q1 24 | $41.4M | $492.8M |
净利润AXGNMASI
| Q4 25 | $-13.2M | — | ||
| Q3 25 | $708.0K | $-100.4M | ||
| Q2 25 | $579.0K | $51.3M | ||
| Q1 25 | $-3.8M | $-170.7M | ||
| Q4 24 | $450.0K | $-349.6M | ||
| Q3 24 | $-1.9M | $9.8M | ||
| Q2 24 | $-1.9M | $16.0M | ||
| Q1 24 | $-6.6M | $18.9M |
毛利率AXGNMASI
| Q4 25 | 74.1% | — | ||
| Q3 25 | 76.6% | 62.1% | ||
| Q2 25 | 74.2% | 62.9% | ||
| Q1 25 | 71.9% | 62.9% | ||
| Q4 24 | 76.1% | 40.7% | ||
| Q3 24 | 74.9% | 52.2% | ||
| Q2 24 | 73.8% | 51.3% | ||
| Q1 24 | 78.8% | 49.0% |
营业利润率AXGNMASI
| Q4 25 | -16.3% | — | ||
| Q3 25 | 3.2% | 22.5% | ||
| Q2 25 | 3.0% | 17.4% | ||
| Q1 25 | -3.4% | 21.0% | ||
| Q4 24 | 4.1% | -59.8% | ||
| Q3 24 | -0.6% | 6.0% | ||
| Q2 24 | -0.9% | 5.7% | ||
| Q1 24 | -11.0% | 6.9% |
净利率AXGNMASI
| Q4 25 | -22.0% | — | ||
| Q3 25 | 1.2% | -27.0% | ||
| Q2 25 | 1.0% | 13.8% | ||
| Q1 25 | -7.9% | -45.9% | ||
| Q4 24 | 0.9% | -58.2% | ||
| Q3 24 | -3.8% | 1.9% | ||
| Q2 24 | -4.0% | 3.2% | ||
| Q1 24 | -16.0% | 3.8% |
每股收益（稀释后）AXGNMASI
| Q4 25 | $-0.28 | — | ||
| Q3 25 | $0.01 | $-1.84 | ||
| Q2 25 | $0.01 | $0.94 | ||
| Q1 25 | $-0.08 | $-3.12 | ||
| Q4 24 | $-0.00 | $-6.54 | ||
| Q3 24 | $-0.04 | $0.18 | ||
| Q2 24 | $-0.04 | $0.29 | ||
| Q1 24 | $-0.15 | $0.35 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $41.5M | $312.3M |
| 总债务越低越好 | $48.4M | $559.1M |
| 股东权益账面价值 | $128.8M | $810.0M |
| 总资产 | $221.7M | $1.8B |
| 负债/权益比越低杠杆越低 | 0.38× | 0.69× |
8季度趋势，按日历期对齐
现金及短期投资AXGNMASI
| Q4 25 | $41.5M | — | ||
| Q3 25 | $35.8M | $312.3M | ||
| Q2 25 | $29.9M | $149.6M | ||
| Q1 25 | $22.1M | $130.8M | ||
| Q4 24 | $33.5M | $177.6M | ||
| Q3 24 | $24.5M | $158.5M | ||
| Q2 24 | $21.1M | $129.6M | ||
| Q1 24 | $17.6M | $157.6M |
总债务AXGNMASI
| Q4 25 | $48.4M | — | ||
| Q3 25 | $48.2M | $559.1M | ||
| Q2 25 | $47.9M | $613.7M | ||
| Q1 25 | $47.7M | $651.0M | ||
| Q4 24 | $47.5M | $765.2M | ||
| Q3 24 | $47.3M | $772.6M | ||
| Q2 24 | $47.0M | $781.6M | ||
| Q1 24 | $46.8M | $876.0M |
股东权益AXGNMASI
| Q4 25 | $128.8M | — | ||
| Q3 25 | $120.8M | $810.0M | ||
| Q2 25 | $112.3M | $1.0B | ||
| Q1 25 | $105.4M | $946.4M | ||
| Q4 24 | $103.9M | $1.1B | ||
| Q3 24 | $99.4M | $1.5B | ||
| Q2 24 | $95.7M | $1.4B | ||
| Q1 24 | $93.2M | $1.4B |
总资产AXGNMASI
| Q4 25 | $221.7M | — | ||
| Q3 25 | $216.4M | $1.8B | ||
| Q2 25 | $205.5M | $2.4B | ||
| Q1 25 | $196.2M | $2.3B | ||
| Q4 24 | $203.7M | $2.6B | ||
| Q3 24 | $192.0M | $3.1B | ||
| Q2 24 | $188.9M | $2.9B | ||
| Q1 24 | $186.5M | $3.0B |
负债/权益比AXGNMASI
| Q4 25 | 0.38× | — | ||
| Q3 25 | 0.40× | 0.69× | ||
| Q2 25 | 0.43× | 0.59× | ||
| Q1 25 | 0.45× | 0.69× | ||
| Q4 24 | 0.46× | 0.73× | ||
| Q3 24 | 0.48× | 0.53× | ||
| Q2 24 | 0.49× | 0.57× | ||
| Q1 24 | 0.50× | 0.64× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $3.0M | $56.8M |
| 自由现金流经营现金流 - 资本支出 | $1.8M | $50.9M |
| 自由现金流率自由现金流/营收 | 3.0% | 13.7% |
| 资本支出强度资本支出/营收 | 2.1% | 1.6% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-2.9M | $191.0M |
8季度趋势，按日历期对齐
经营现金流AXGNMASI
| Q4 25 | $3.0M | — | ||
| Q3 25 | $3.2M | $56.8M | ||
| Q2 25 | $7.7M | $69.4M | ||
| Q1 25 | $-13.2M | $31.1M | ||
| Q4 24 | $8.7M | $50.5M | ||
| Q3 24 | $3.9M | $25.6M | ||
| Q2 24 | $4.2M | $74.5M | ||
| Q1 24 | $-12.3M | $45.8M |
自由现金流AXGNMASI
| Q4 25 | $1.8M | — | ||
| Q3 25 | $1.7M | $50.9M | ||
| Q2 25 | $7.0M | $65.6M | ||
| Q1 25 | $-13.4M | $28.5M | ||
| Q4 24 | $8.1M | $46.0M | ||
| Q3 24 | $3.3M | $16.9M | ||
| Q2 24 | $3.3M | $66.9M | ||
| Q1 24 | $-13.2M | $37.6M |
自由现金流率AXGNMASI
| Q4 25 | 3.0% | — | ||
| Q3 25 | 2.8% | 13.7% | ||
| Q2 25 | 12.4% | 17.7% | ||
| Q1 25 | -27.7% | 7.7% | ||
| Q4 24 | 16.3% | 7.7% | ||
| Q3 24 | 6.8% | 3.3% | ||
| Q2 24 | 6.8% | 13.5% | ||
| Q1 24 | -31.9% | 7.6% |
资本支出强度AXGNMASI
| Q4 25 | 2.1% | — | ||
| Q3 25 | 2.5% | 1.6% | ||
| Q2 25 | 1.3% | 1.0% | ||
| Q1 25 | 0.5% | 0.7% | ||
| Q4 24 | 1.4% | 0.7% | ||
| Q3 24 | 1.2% | 1.7% | ||
| Q2 24 | 1.9% | 1.5% | ||
| Q1 24 | 2.2% | 1.7% |
现金转化率AXGNMASI
| Q4 25 | — | — | ||
| Q3 25 | 4.55× | — | ||
| Q2 25 | 13.35× | 1.35× | ||
| Q1 25 | — | — | ||
| Q4 24 | 19.41× | — | ||
| Q3 24 | — | 2.61× | ||
| Q2 24 | — | 4.66× | ||
| Q1 24 | — | 2.42× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
